Literature DB >> 12880751

Respiratory virus infections in cystic fibrosis.

Dennis Wat1, Iolo Doull.   

Abstract

Respiratory virus infections have pronounced and long-lasting effects on patients with cystic fibrosis (CF), resulting in significant declines in FVC, FEV(1) and Shwachman score, significantly increasing both the frequency and duration of hospitalisation. Deleterious effects on patients with CF have been reported for most viruses studied but the effects of respiratory syncytial virus and influenza appear the greatest. There is circumstantial evidence that respiratory virus infections may facilitate bacterial infections, particularly Pseudomonas aeruginosa.

Entities:  

Mesh:

Year:  2003        PMID: 12880751     DOI: 10.1016/s1526-0542(03)00059-9

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  23 in total

1.  Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.

Authors:  Anna R Kwilas; Mark A Yednak; Liqun Zhang; Rachael Liesman; Peter L Collins; Raymond J Pickles; Mark E Peeples
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

Review 2.  Spectrum of viral infections in patients with cystic fibrosis.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

3.  Rhinovirus infection liberates planktonic bacteria from biofilm and increases chemokine responses in cystic fibrosis airway epithelial cells.

Authors:  Sangbrita S Chattoraj; Shyamala Ganesan; Andrew M Jones; Jennifer M Helm; Adam T Comstock; Rowland Bright-Thomas; John J LiPuma; Marc B Hershenson; Umadevi S Sajjan
Journal:  Thorax       Date:  2011-02-02       Impact factor: 9.139

4.  The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis.

Authors:  Julia Eckardt-Michel; Markus Lorek; Diane Baxmann; Thomas Grunwald; Günther M Keil; Gert Zimmer
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

5.  Pseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis but not in normal bronchial epithelial cells.

Authors:  Sangbrita S Chattoraj; Shyamala Ganesan; Andrea Faris; Adam Comstock; Wai-Ming Lee; Umadevi S Sajjan
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

Review 6.  Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis.

Authors:  Christopher H Goss; Jane L Burns
Journal:  Thorax       Date:  2007-04       Impact factor: 9.139

7.  Ten years of viral and non-bacterial serology in adults with cystic fibrosis.

Authors:  I J Clifton; J A Kastelik; D G Peckham; A Hale; M Denton; C Etherington; S P Conway
Journal:  Epidemiol Infect       Date:  2007-03-12       Impact factor: 2.451

8.  Influenza-associated cystic fibrosis pulmonary exacerbations.

Authors:  Justin R Ortiz; Kathleen M Neuzil; John C Victor; Anna Wald; Moira L Aitken; Christopher H Goss
Journal:  Chest       Date:  2009-12-04       Impact factor: 9.410

9.  Adenovirus-mediated gene therapy enhances parainfluenza virus 3 infection in neonatal lambs.

Authors:  David K Meyerholz; Branka Grubor; Jack M Gallup; Howard D Lehmkuhl; Richard D Anderson; Tatjana Lazic; Mark R Ackermann
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 10.  Liquid movement across the surface epithelium of large airways.

Authors:  Lucy A Chambers; Brett M Rollins; Robert Tarran
Journal:  Respir Physiol Neurobiol       Date:  2007-06-17       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.